Patent ID: 9095560
Filing Date: 2015-08-04
Classification: A61K,A61P

Abstract:
1. A method of transdermally administering an active ingredient, comprising: applying a lyotropic liquid crystal compounded with the active ingredient to a skin surface of a person in need of transdermal administration of the active ingredient, wherein said lyotropic liquid crystal contains 15.026% by weight to 28% by weight of a surfactant and 5% by weight to 80% by weight of water, wherein said active ingredient is a macromolecular substance having a molecular weight of not less than 1,000 daltons, wherein said surfactant is polyoxyethylene octyl dodecyl ether, wherein said lyotropic liquid crystal further contains 16.819% by weight to 25% by weight of squalane, wherein said lyotropic liquid crystal further contains 1% by weight to 55% by weight of glycerol.